UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000008793
Receipt No. R000010332
Scientific Title Phase II study of remission induction therapy with bendamustine and rituximab combination (BR) therapy followed by consolidation therapy with 90Y-labeled iburitumomab tiuxetan for relapsed follicular lymphoma.(BRiZ2012 protocol)
Date of disclosure of the study information 2012/09/03
Last modified on 2019/03/04 09:44:53

No. Disposal Last modified on Item of update
1 Insert 2012/08/28 19:50:54
2 Update 2013/07/16 18:01:17 Recruitment status
3 Update 2013/09/02 12:00:29 Email
Institutions
4 Update 2014/09/02 14:27:21 Interventions/Control_1
Interventions/Control_1
Key inclusion criteria
Key inclusion criteria
5 Update 2014/09/02 14:37:22 Institute
Institutions
6 Update 2014/09/02 14:38:51 Last follow-up date
7 Update 2016/05/06 09:19:19 Recruitment status
8 Update 2016/09/01 09:27:03 Name of primary sponsor
Organization
Institutions
9 Update 2019/03/04 09:44:53 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
Results
Other related information


Contact us.